Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE-WEEKLY BEROBENATIDE IN ADULTS WITH KNEE OSTEOARTHRITIS AND OVERWEIGHT OR OBESITY WITH OR WITHOUT TYPE 2 DIABETES (VESPER-OA 2)

NCT07915609 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07915609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE-WEEKLY BEROBENATIDE IN ADULTS WITH KNEE OSTEOARTHRITIS AND OVERWEIGHT OR OBESITY WITH OR WITHOUT TYPE 2 DIABETES (VESPER-OA 2)
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Recruiting
Start date
October 26, 2026
Completion date
October 30, 2028
Enrollment
756 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes melliuts, type 2, knee osteoarthritis, obesity, overweight and/or obesity

Arms

As registered; 4 arms.

  • Placebo Placebo comparatorPlacebo

    Placebo

  • Arm 1: Berobenatide Once Weekly ExperimentalBerobenatide

    Berobenatide Once Weekly

  • Arm 2: Berobenatide Once Weekly ExperimentalBerobenatide

    Berobenatide Once Weekly

  • Arm 3: Berobenatide Once Weekly ExperimentalBerobenatide

    Berobenatide Once Weekly

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change from Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale score Baseline and Week 52

Lead sponsor's other trials

Pfizer, most recent start first.

Similar trials

Same condition (Osteoarthritis, Knee) and phase, most recent start first.